Share ownership ANGLE plc

AGL

GB0034330679

Advanced Medical Equipment & Technology

Delayed London S.E. Other stock markets 15:50:43 13/09/2024 BST			5-day change	1st Jan Change
11.07 ^GBX	-1.64%		-7.78%	-5.82%

08-23	Angle hails publication of research data in science journal	AN
08-22	Angle plc Announces the Publication of One of the Company's Clinical Studies That Was Submitted to the FDA for De Novo Regulatory Clearance of the Parsortix PC1 System	CI

Share class: ANGLE plc

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	322,641,668	270,379,309 ( 83.80 %)	0	83.80 %

Major shareholders: ANGLE plc

Name	Equities	%	Valuation
Dermot Keane 8.106 %	26,152,590	8.106 %	5 M p
Global Frontier Investments LLC 6.846 %	22,088,946	6.846 %	4 M p
Hargreaves Lansdown Asset Management Ltd. 3.286 %	10,603,000	3.286 %	2 M p
Baillie Gifford & Co. 2.496 %	8,051,990	2.496 %	1 M p
Chelverton Asset Management Ltd. 2.328 %	7,512,113	2.328 %	1 M p
Global Prime Partners Ltd. 1.886 %	6,086,000	1.886 %	1 M p
Aegon Asset Management UK PLC 1.639 %	5,287,903	1.639 %	920 835 p
Aidan Waine 1.551 %	5,005,000	1.551 %	871 571 p
IG Markets Ltd. 1.190 %	3,839,000	1.190 %	668 523 p
Jarvis Investment Management Ltd. 1.070 %	3,452,000	1.070 %	601 131 p
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	29.79%
Individuals	9.94%
Other	2.13%
Unknown	58.14%

Based on 1000 largest holdings

Geographical origin of shareholders

United Kingdom	22.27%
Individuals	9.94%
United States	9.10%
Switzerland	0.33%
France	0.19%
Sweden	0.02%
Spain	0.02%

Based on 1000 largest holdings

ANGLE plc is a United Kingdom-based liquid biopsy company with circulating tumor cell (CTC) solutions for use in research, drug development and clinical oncology using a simple blood sample. Its circulating tumor cell (CTC) harvesting technology known as the Parsortix PC1 System enables complete downstream analysis of the sample, including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. The Parsortix PC1 system is a medical device for the capture and harvest of intact CTCs from metastatic breast cancer (MBC) patient blood for user-validated analysis. Its commercial businesses focus on diagnostic products and clinical services. Its diagnostic products include the Parsortix system and associated consumables. Its services include custom made assay development and clinical trial testing for pharma. The Parsortix technology uses a microfluidic technology in the form of a single use cassette to capture and then harvest CTCs from whole blood.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

25/09/2024 - Q2 2024 Earnings Release (Projected)

More about the company